Cargando…
Tolerability and impact of SARS-CoV-2 vaccination in elite athletes
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664388/ https://www.ncbi.nlm.nih.gov/pubmed/34902331 http://dx.doi.org/10.1016/S2213-2600(21)00548-8 |
_version_ | 1784613836196675584 |
---|---|
author | Hull, James H Wootten, Moses Ranson, Craig |
author_facet | Hull, James H Wootten, Moses Ranson, Craig |
author_sort | Hull, James H |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8664388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86643882021-12-14 Tolerability and impact of SARS-CoV-2 vaccination in elite athletes Hull, James H Wootten, Moses Ranson, Craig Lancet Respir Med Correspondence Elsevier Ltd. 2022-01 2021-12-11 /pmc/articles/PMC8664388/ /pubmed/34902331 http://dx.doi.org/10.1016/S2213-2600(21)00548-8 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Hull, James H Wootten, Moses Ranson, Craig Tolerability and impact of SARS-CoV-2 vaccination in elite athletes |
title | Tolerability and impact of SARS-CoV-2 vaccination in elite athletes |
title_full | Tolerability and impact of SARS-CoV-2 vaccination in elite athletes |
title_fullStr | Tolerability and impact of SARS-CoV-2 vaccination in elite athletes |
title_full_unstemmed | Tolerability and impact of SARS-CoV-2 vaccination in elite athletes |
title_short | Tolerability and impact of SARS-CoV-2 vaccination in elite athletes |
title_sort | tolerability and impact of sars-cov-2 vaccination in elite athletes |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664388/ https://www.ncbi.nlm.nih.gov/pubmed/34902331 http://dx.doi.org/10.1016/S2213-2600(21)00548-8 |
work_keys_str_mv | AT hulljamesh tolerabilityandimpactofsarscov2vaccinationineliteathletes AT woottenmoses tolerabilityandimpactofsarscov2vaccinationineliteathletes AT ransoncraig tolerabilityandimpactofsarscov2vaccinationineliteathletes |